DNA, Myriad | JD Supra Law News

The Myriad Case and "Gene" Patents: Much Ado about Nothing?

by Kevin E. Noonan | McDonnell Boehnen Hulbert & Berghoff LLP on 5/15/2013

The biggest concern of the biotechnology industry caused by the impending Supreme Court decision in the AMP v. Myriad Genetics case is the threat to existing patents having claims to isolated human DNA (and the DNA from other...more

Bernstein Shur Business and Commercial Litigation Newsletter #27

by Paul McDonald, Daniel J. Murphy | Bernstein Shur on 5/2/2013

We are pleased to present the 27th edition of the Bernstein Shur Business and Commercial Litigation Newsletter. This month, we highlight stories that will have an impact on business, commerce and litigation, including the...more

Supreme Debate: Are Human Genes Patentable?

by Therese Finan | Venable LLP on 5/1/2013

On April 15, 2013, tackling an issue of significant importance to the biotechnology and health care industries, the U.S. Supreme Court heard oral arguments over whether human genes are patentable and more specifically,...more

[Legal Perspective] Can Human Genes Be Patented?

by JD Supra Law News on 4/24/2013

Earlier this month, the United States Supreme Court heard oral arguments in a case that comes down to a single question: can human genes be patented?...more

What We May Learn from the Myriad Oral Argument

by Kevin E. Noonan | McDonnell Boehnen Hulbert & Berghoff LLP on 4/19/2013

The U.S. Supreme Court heard oral argument in Association for Molecular Pathology v. Myriad Genetics, Inc. on Monday, and many have commented on the Court's interrogation of the parties' representatives (and the government)...more

Can You Patent Human Genes? ACLU Says No [Video]

by Bloomberg Law on 4/12/2013

April 12 (Bloomberg Law) -- On April 15, 2013, the United States Supreme Court will hear oral arguments for Association for Molecular Pathology v. Myriad Genetics, Inc. The case centers on whether patents may be granted on...more

Genome Medicine Article Calls for Limits on Patenting of Existing Nucleotide Sequences

by Donald Zuhn | McDonnell Boehnen Hulbert & Berghoff LLP on 4/3/2013

In an article published in the current issue of Genome Medicine, Jeffrey Rosenfeld of the University of Medicine & Dentistry of New Jersey and Christopher Mason of Cornell University contend that due to the non-specificity of...more

Supreme Court To Hear Oral Arguments in Landmark Patent Case

by Baker, Donelson, Bearman, Caldwell &... on 3/28/2013

April 15 is a big day for biotechnology, pharmaceutical, and medical diagnostic companies at the Supreme Court, as justices begin a new session by hearing oral arguments in a landmark case involving the patentability of...more

Is Lack of Preemption the Key for the Supreme Court to Decide in Myriad's Favor?

by Kevin E. Noonan | McDonnell Boehnen Hulbert & Berghoff LLP on 3/27/2013

The U.S. Supreme Court will hear arguments in Association for Molecular Pathology v. Myriad Genetics, Inc. on April15th, and the parties and their different cadres of amici have submitted briefs of varying degrees of...more

Isolated Nucleic Acids Are Patentable – What Does The “Myriad” Decision In Australia Mean For Patent Applicants?

by Karen Bentley, Adam Denley | Freehills Patent Attorneys on 2/21/2013

In a landmark decision regarding the patentability of genetic material, the Federal Court of Australia has held that any nucleic acid found in cells, whether it be DNA or RNA, that has been removed from the cellular...more

Australian Federal Court Upholds Myriad’s Gene Patent

by James J. Mullen, III, Mary Prendergast | Morrison & Foerster LLP on 2/19/2013

While the question of patentability of isolated gene sequences awaits resolution at the U.S. Supreme Court, the Australian Federal Court today upheld Myriad Genetics’ patent on methods for screening for cancer-predisposing...more

Myriad Posts Gene Patenting Victory in Australia

by Antoinette F. Konski | Foley & Lardner LLP on 2/19/2013

In a companion case to the “gene patenting” dispute presently before the U.S. Supreme Court, Myriad Genetics, Inc. successfully defended the patent-eligibility of “gene patents” in Australia. In Cancer Voices et al. v. Myriad...more

Isolated Nucleic Acids Are Patentable – Landmark “Myriad” Decision In Australia

by Karen Bentley, Adam Denley | Freehills Patent Attorneys on 2/15/2013

In a landmark decision regarding the patentability of genetic material, the Federal Court of Australia has held that any nucleic acid found in cells, whether it be DNA or RNA, that has been removed from the cellular...more

United States Asks Supreme Court to Affirm on cDNA, Reverse on Isolated, Unmodified DNA

by Donald Zuhn | McDonnell Boehnen Hulbert & Berghoff LLP on 2/13/2013

In an amicus brief filed last month in Association for Molecular Pathology v. Myriad Genetics, Inc., the United States asks the Supreme Court to affirm the judgment of the Federal Circuit that cDNA is patent-eligible and...more

Is It Time for Myriad to Concede in AMP v. Myriad for the Good of the Biotechnology Industry?

by Kevin E. Noonan | McDonnell Boehnen Hulbert & Berghoff LLP on 1/24/2013

The Supreme Court's grant of certiorari over the question "Are human genes patentable" had raised for many the specter of an uninformed generalist court rendering a decision containing dicta that would negatively affect...more

“Are Human Genes Patentable?” The Supreme Court Grants Certiorari in Myriad

by Randy V. Clower | Phillips Lytle LLP on 12/20/2012

On November 30, 2012, the Supreme Court granted certiorari – in what portends to be one of the most impactful decisions in patent law history – to end the “gene patenting” debate, an issue that lower courts have measured over...more

Supreme Court to Consider Whether (Isolated) Human Genes are Patentable

by Lars H. Genieser, Ph.D., Fabian M. Koenigbauer | Venable LLP on 12/19/2012

On November 30, 2012, the U.S. Supreme Court agreed to decide a case presenting the seemingly simple, but legally complex, question, “Are human genes patentable?” After Bilski v. Kappos, 130 S. Ct. 3218 (2010) and Mayo...more

The Patentability of Isolated DNA Will be Decided by the Supreme Court

by Robert W. Esmond, Ph.D., Eric K. Steffe | Sterne, Kessler, Goldstein & Fox P.L.L.C. on 12/4/2012

On November 30, 2012, the U.S. Supreme Court agreed to review the Federal Circuit decision in Association for Molecular Pathology v. Myriad Genetics, holding that isolated human genes are patent-eligible under 35 U.S.C. §...more

Myriad Finally Gets Its Day in (the Supreme) Court

by James J. Mullen, III, Mary Prendergast | Morrison & Foerster LLP on 12/3/2012

INTRODUCTION - The Supreme Court today granted certiorari in Assoc. for Molecular Pathology, et al. v. U.S. Patent and Trademark Office, et al. (Myriad), to address the issue of whether human genes are patentable. This...more

Myriad Files Responsive Brief Opposing Certiorari

by Kevin E. Noonan | McDonnell Boehnen Hulbert & Berghoff LLP on 11/30/2012

On Halloween, Myriad Genetics filed its brief in opposition to plaintiffs' petition for certiorari in Association for Molecular Pathology v. Myriad Genetics, Inc. (plaintiffs nominally being the Association for Molecular...more

Myriad Responds: ACLU Asks the Wrong Question

by Antoinette F. Konski | Foley & Lardner LLP on 11/15/2012

On October 31, 2012, Myriad Genetics, Inc. et al. (“Respondent” or “Myriad”) filed its brief in opposition to Petitioners’ (The Association for Molecular Pathology et al., represented by the American Civil Liberties Union or...more

Myriad Genetics Notches Another Legal Victory

by Konstantin Linnik, JD, PhD on 9/6/2012

Sept 6, 2012, Cancer Discover--Myriad Genetics of Salt Lake City, UT, can check off another legal victory on its BRCA1 and BRCA2 patent claims. On August 16, 2012, the U.S. Court of Appeals for the Federal Circuit in...more

Federal Circuit Again Upholds Patent-Eligibility of Myriad's Isolated DNA Claims, Holds Diagnostic “Analyzing” Claims...

by Foley & Lardner LLP on 8/16/2012

On August 16, 2012, in the most recent decision in one of the most controversial and publicized biotech patent cases in many years, the Federal Circuit again decided the “ACLU/Myriad” gene patenting case (formally, The...more

Federal Circuit Reaffirms the Patentability of Isolated DNA in Association for Molecular Pathology v. Myriad

by Sterne, Kessler, Goldstein & Fox P.L.L.C. on 8/16/2012

On August 16, 2012, the U.S. Court of Appeals for the Federal Circuit issued another split decision in Association for Molecular Pathology v. Myriad Genetics, No. 2010-1406 (Myriad). Each of the three categories of claims...more

Home

Legal News

Find a Lawyer

Browse Subjects

Subscribe

Pro Services

For Reporters

DNA › Myriad

The Myriad Case and "Gene" Patents: Much Ado about Nothing?

Bernstein Shur Business and Commercial Litigation Newsletter #27

Supreme Debate: Are Human Genes Patentable?

[Legal Perspective] Can Human Genes Be Patented?

What We May Learn from the Myriad Oral Argument

Can You Patent Human Genes? ACLU Says No [Video]

Genome Medicine Article Calls for Limits on Patenting of Existing Nucleotide Sequences

Supreme Court To Hear Oral Arguments in Landmark Patent Case

Is Lack of Preemption the Key for the Supreme Court to Decide in Myriad's Favor?

Isolated Nucleic Acids Are Patentable – What Does The “Myriad” Decision In Australia Mean For Patent Applicants?

Australian Federal Court Upholds Myriad’s Gene Patent

Myriad Posts Gene Patenting Victory in Australia

Isolated Nucleic Acids Are Patentable – Landmark “Myriad” Decision In Australia

United States Asks Supreme Court to Affirm on cDNA, Reverse on Isolated, Unmodified DNA

Is It Time for Myriad to Concede in AMP v. Myriad for the Good of the Biotechnology Industry?

Top Three Stories of 2012

“Are Human Genes Patentable?” The Supreme Court Grants Certiorari in Myriad

Supreme Court to Consider Whether (Isolated) Human Genes are Patentable

The Patentability of Isolated DNA Will be Decided by the Supreme Court

Myriad Finally Gets Its Day in (the Supreme) Court

Myriad Files Responsive Brief Opposing Certiorari

Myriad Responds: ACLU Asks the Wrong Question

Myriad Genetics Notches Another Legal Victory

Federal Circuit Again Upholds Patent-Eligibility of Myriad's Isolated DNA Claims, Holds Diagnostic “Analyzing” Claims...

Federal Circuit Reaffirms the Patentability of Isolated DNA in Association for Molecular Pathology v. Myriad

Can You Patent Human Genes? ACLU Says No [Video]

Expand Your Reach